Vactosertib (TEW-7197) Mechanism of Action: TGFBR1 Inhibition in T Cell Research

Vactosertib (TEW-7197) MOA:Targeting TGFBR1/TGF-β Pathway for Solid Tumor Oncology

🎯 check Vactosertib (TEW-7197) product page

Vactosertib (TEW-7197) is a potent, orally available TGF-β RI/ALK5 inhibitor. It affects TGF-β/Smad signaling by blocking ALK5 kinase activity and Smad2/3 phosphorylation, effectively inhibiting fibrosis, epithelial-mesenchymal transition, and tumor progression.

Primary Applications and Mechanism of Action